NCT07089199
- Conditions
- Anlotinib, NSCLC, Nab-paclitaxel, +1 more
- Locations
-
- Qilu Hospital of Shandong University Jinan, Shandong, China
Clinical trial condition
Explore clinical trials studying Tislelizumab. Study availability and eligibility vary by location and protocol.
NCT07089199
NCT07339488
NCT07458529
NCT07233252
NCT07198217
NCT07125547
NCT07086456
NCT07085182
NCT05920863
NCT05970302